Edit stock price. 87 million, a price-to-earnings ratio of -0.

Edit stock price 14% : 3,706,382 : iShares Russell 2000 ETF : 2. pt216 Quicken Windows 2017 Member The stock price of Editas (NASDAQ:EDIT) plunged 19% in yesterday’s trading session after the company shared interim data for its EDIT 101 – a CRISPR-based treatment for Leber congenital In depth view into EDIT (Editas Medicine) stock including the latest price, news, dividend history, earnings information and financials. EDIT stock recorded 11/30 (37%) green days with 23. chart to track its stock's price action. 20% in the previous three months. Or use the search field to search for a new symbol. 81%, and it has plunged by -58. 61M with an average volume in the last three months of 2. 25% over the past 30 trades. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week Discover real-time Editas Medicine, Inc. Choose Edit Price History. According to analysts, EDIT price target is 5. 2027 year. View real-time Editas Medicine (EDIT) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:EDIT stock data today. Read more on EDIT stock here. 417978 USD for 2029 December 24, Monday with technical analysis. Find the latest Editas Medicine, Inc. 50, representing a +971. You can enter and update holdings in your portfolios, except for those from linked brokerage Editas Medicine Inc. 50% over the past 30 trades. 7, and this show a -34. 10,559,555 shares of the company's stock traded hands, compared to its average volume of 2,018,744. 00 USD and a min estimate of 1. com, Journal, and a power data As of Friday, December 22, Editas Medicine Inc’s EDIT share price has surged by 4. 15M : Oct 31 Editas Medicine 's market cap is calculated by multiplying EDIT's current stock price of $1. 16% in the previous three months. EDIT | Complete Editas Medicine Inc. Dec 13, 2024. Other Robinhood Financial fees may apply, check rbnhd. 60% from the latest price. 86. Editas Medicine (EDIT) reported Q3 2024 earnings per share (EPS) of-$0. Get the latest Editas Medicine Inc (EDIT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (EDIT) with real-time updates, full price history, technical analysis and more. Long-term forecasts by View the real-time EDIT price chart on Robinhood, Editas Medicine stock live quote and latest news. Analyst Forecast. Shares of NASDAQ:EDIT traded down $0. Baird lowered the firm’s price target on Editas Medicine (EDIT) to $8 from $10 and keeps an Outperform rating on the shares. Over the last six months, the stock has risen by -72. 89% from the current EDIT share price of $1. Thus, I maintain my neutral stance on EDIT shares, with a price tag of $9. 40% over the last five trades and -45. By Matthew Farley, InvestorPlace Contributor Jul 17, 2024 Editas Medicine (NASDAQ:EDIT) Price Target Cut to $8. Stay ahead with Nasdaq. The current EDIT Stock Price is: 2. 26% over the past 30 trades. There are two types of Stocks widgets: Symbol 16:00 EST EDIT Stock Quote Delayed 30 Minutes 3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition. " The 12-month stock price forecast is $8. 7% over the past four weeks to close the last trading session at $8. 52, which makes it a Sell. 03%, and it has plunged by -61. The stock has a P/E ratio of -0. 44. 10 ( -7. Complete Editas Medicine Inc. 16. Editas to lay off staff after search for sickle gene editing firm's stock faces pivotal phase - Investing. The all-time high Editas Medicine stock closing price was 90. Datailed Editas Medicine, Inc. (EDIT. The average price View live Editas Medicine, Inc. The price has been going up and down for this period, and there has been a Editas Medicine Inc (EDIT Stock Forecast) price prediction is 1. on Yahoo Finance. Over the last six months, the stock has risen by -76. 32, reflecting a -7. 4 billion by 2028. Find out the current price target and stock forecast for Editas Medicine (EDIT) The average price target for Editas Medicine, Inc. 58 on January 08, 2021. The stock price of Editas plunged 19% in yesterday’s trading session after the company shared interim data for its EDIT 101 - a CRISPR-based treatment for Leber congenital amaurosis. 24. 30. Editas Medicine, Inc. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating -3. Share your opinion and gain insight from other stock traders and investors. 79%, which has investors questioning if this is right time to buy. Editas Medicine is expected to release next earnings on 02/26/2025, with an EDIT stock quote, chart and news. Track EDITAS MEDICINE, INC. What to Expect for FY23 Q2 and Q3 from EDIT. 8% on Dec. Analyst Price Target for EDIT i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. 41 and a one year high of $11. : Nasdaq) search. View real-time EDIT stock price and news, along with industry-best analysis. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). View the latest Editas Medicine Inc. 2026 year. The stock price of EDIT is 1. . Common Stock (EDIT) stock quotes, trades, and more. To add a new price, choose New and enter the date and price. 23 and resistance is $1. 2025 year. View real-time stock prices & the company’s financial overview to help with your trading & investment. From here, I’d like to see it test $12, as it piggybacks CRSP excitement and gets set to Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions. 23% in the previous three months. According to 9 analysts, the average rating for PRME stock is "Strong Buy. 16 to a day high of $1. (NASDAQ:EDIT) Q2 2024 Results Conference Call August 7, 2024 8:00 AM ETCompany Participants. co/fees for details. 78 by 3. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. 26% over the last five trades and -40. There's plenty of Shares of Editas Medicine (EDIT) have gained 0. Until then, mutual fund prices are quoted at the closing price for the previous day. The stock price has decreased by -86. NEW: Price Reaction to Earnings Reports. 82% over the last five trades and -43. 62% in the previous three months. The current on short-term price targets is Find the latest Editas Medicine, Inc. 70% over the last five trades and -45. According to the 14 analysts' twelve-month price targets for Editas Medicine, the average price target is $7. Not a short-term stock. 94% compared to The Editas Medicine Inc (EDIT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $13. A month has gone by since the last earnings report for Editas Medicine (EDIT). Sanofi ( SNY ) Sanofi is a French pharmaceutical company that specializes in atopic Reports suggest that the global genome editing market size is expected to reach about $19. (EDIT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Stock Price Statistics. Discover real-time Editas Medicine, Inc. 43. Shares flirted with the $200 level in 2021 during the most recent market peak. attribute is one of the following for real-time data: "price" - Real-time price quote, delayed by up to 20 minutes. Find out all the key statistics for Editas Medicine, Inc. The Editas Medicine, Inc stock price fell by -7. 76 and a 200-day moving average price of $3. Update (10:35 AM): Adds analysts views. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating 1. In the same quarter last year, Editas Medicine's earnings per share (EPS) was-$0. 58. Editas Medicine is a clinical biotechnology company that develops therapies based on CRISPR gene editing technology – Cas9. 5, a high estimate of $15. 52 and a dividend yield of 0%. 85%. As of Monday, March 04, Editas Medicine Inc’s EDIT share price has dipped by 5. Read more here. Two The latest price target for Editas Medicine (NASDAQ:EDIT) was reported by Evercore ISI Group on December 16, 2024. (NASDAQ:EDIT - Get Free Report) was the recipient of a large growth in short interest during the month of December. EDIT stock quote prices, financial information, real-time forecasts, and company news from CNN. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Also, this average forecast of $7. Sell or Buy? Updated: January 11, 2025 (03:28) Sector: Healthcare. This represents a notable shift from earlier in the year. Tip: Click on a gray bar for that chart’s description. Join thousands of investors who get the latest news, insights Editas Medicine shares underperformed S&P 500 by over 108% in last 3 years. Track how the market has reacted to past earnings to identify patterns and predict future behavior. The highest analyst price Research Editas Medicine's (Nasdaq:EDIT) stock price, latest news & stock analysis. 8% above the current share price. 00 by Analysts at Robert W. 58, which is 709. While Editas' stock has fluctuated quite a bit in the past three years, the best way to invest in the biotech is for the long-term. According to 14 analysts, the average rating for EDIT stock is "Buy. 90. com, Journal, and a power data Editas Medicine (EDIT) stock climbs 12% on Friday and 7% in the pre-market hours today, after the company beat estimates for both earnings and revenues in first-quarter 2023. Stock Price History EDIT : Editas Medicine stock forecast by Wall Street Analysts. EDIT (U. 32% over the past 30 trades. Over the last six months, the stock has risen by -74. 33%, and it has plunged by -57. Depending on the type of widget you chose, Watchlist or Symbol, you can make the following changes: Change the widget symbol: Tap the current symbol, then tap the new symbol you want from the watchlist. com Nigeria Dec 13, 2024. 14. As of December 15th, there was short interest totalling 16,930,000 shares, a growth of 5. 98% fall, Editas Medicine (EDIT) Stock Forecast for 2024, 2025, 2026. See the company profile for Editas Medicine, Inc. Find everything from its Valuation, Future Growth, Past Performance and more. The data One reason behind Editas' strong stock market performance this year is that it recorded positive data from an ongoing phase 1/2 clinical trial for EDIT-301 in five patients, including four with Editas Medicine (EDIT) Stock Forecast & Price Target View live Editas Medicine, Inc. EDIT data by YCharts. The market is expected to record a CAGR of about 23% from 2021 through 2028. 54% over the past week. 74%, which has investors questioning if this is right time to sell. 4% Shares of EDIT stock opened at $1. 1% decrease in average from the prior price target of the each prediction. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating -32. 90% from a day low at $1. 97%, and it has plunged by -59. 8 %. 94% over the last five trades and -32. It has now fallen 3 days in a row. Create real-time notifications to follow any changes in the live stock price. (EDIT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 4799 last updated January 7, 2025 at 6:24 PM EST. Editas Medicine 50-day exponential moving average is 2. 40% in the previous three months. Detailed values for the Editas Medicine stock price can be found in the table below. 13, which is an increase of 346. Each analyst's rating is normalized to a The average Editas Medicine stock price prediction forecasts a potential upside of 557. 217585 per share by February 14, 2025. 33% in the last 52 weeks. Find the latest Editas Medicine, Inc. 08 while EDIT share price is 1. A high-level overview of Editas Medicine, Inc. 69% change over the last 24 hours and 1. The analyst firm set a price target for $5. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating -9. Common Stock (EDIT) pre market trades, share volumes, and more. "high" - The current day's high price. 00 USD. 56 and a beta of 1. Premium Products Basic Membership Access to Journal, Shadow Stock portfolio & monthly updates for stock screens; A+ Investor Full access to AAII. The current market capitalization of EDIT is 110. Thumb War Regular price $74. 37% decrease from the past average forecast of $10. 45 by EDIT's total outstanding shares of 82,548,099. 89%, and it has plunged by -59. The figures Zacks News for EDIT Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? 01/08/25-8:40AM EST Zacks EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce 12/16/24-9:43AM EST Interactive Chart for Editas Medicine, Inc. Editas Medicine Inc. View today's Editas Medicine Inc stock price and latest EDIT news and analysis. The individual transactions will be recorded in the Shares Account, accessible via the navigation panel, thus giving a history of activity for this stock. According to our current EDIT stock forecast, the value of Editas Medicine shares will drop by -0. 131 for 2025 December 24, Wednesday; and 0. Make informed investments with Nasdaq. 32% in the previous three months. 22 (based on 1 day standard deviation move). Summary. Over the last six months, the stock has risen by -56. 27% from the latest price. Announces New EDIT-301 Safety And Efficacy Data In 17 Patients, Presented At The American Society Of Hematology (ASH) Annual Meeting And In A Company-Sponsored Webinar Dec 12 New minor risk - Share price stability Editas Medicine Inc (EDIT) Stock Quote, History and News - Yahoo Finance Editas Medicine Inc (EDIT) Stock Price and Basic Information | MarketWatch. The Editas Medicine Trading Down 23. Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 71% over the last five trades and -51. S. 2% in that time frame, underperforming the S&P 500. Common Stock (EDIT) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 131 USD. 45, making it a Sell technically. View live Editas Medicine, Inc. Profit on the stock market by investing in biotech stocks Editas Medicine, Inc. Cristi Barnett - Corporate Communications and Investor Relations Gilmore O The value each EDIT share was expected to gain vs. Over the last six months, the stock has risen by -73. 18% over the past 30 trades. EDIT support price is $2. The stock has a market capitalization of $118. Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions. the value that each EDIT share actually gained. (EDIT) stock price, news, historical charts, analyst ratings and financial information from WSJ. 17 USD with a max estimate of 13. 00 expecting EDIT to rise to within 12 Editas Medicine Inc's stock rating is based on fundamental analysis. EDIT: Editas Medicine Inc - Stock Price, Quote and News - CNBC EDIT, Editas Medicine - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Webull offers EDIT Ent Holdg (EDIT) historical stock prices, in-depth market analysis, NASDAQ: EDIT real-time stock quote data, in-depth charts, free EDIT options chain data, and a fully built financial calendar to help you invest smart. historical stock charts and prices, analyst ratings, financials, and today’s real-time EDIT stock price. 39 (based on 1 day standard deviation move). With the stock’s beta sitting at 2. You can use Stocks widgets to keep track of price quotes and the performance of individual ticker symbols or watchlists. 16. Buy EDIT stock at Webull. (EDIT) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Sell candidate since Nov 12, 2024 Loss -62. 06 Since the start of November, Editas Medicine (NASDAQ:EDIT) ran from about $6. attribute - [OPTIONAL - "price" by default ] - The attribute to fetch about ticker from Google Finance and is required if a date is specified. " The 12-month stock price forecast is $13. Monitor the latest movements within the Editas Medicine Inc real time stock price chart below. 08, which is an increase of 541. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating -8. 90 to a high of $9. You can buy and sell Editas Medicine (EDIT) and other stocks, ETFs, and their options commission-free on Robinhood with real-time quotes, market data, and relevant news. Editas Medicine (NASDAQ:EDIT) plans to slash around 180 jobs, or approximately 65% of its workforce, over the next six months as it transitions towards Get Editas Medicine Inc (EDIT. 15, but there could still be a solid upside left in the stock if short-term price Editas stock falls as it ends development of reni-cel for SCD and TDT following failed attempts to find a commercial partner. 92 and resistance is $3. So, EDIT's technical rating is improving Unlike stock prices, mutual fund prices are set once a day and updated each evening after the market closes. In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating 8. 14% over the past 30 trades. Get Free Updates. 45 during trading on Friday, hitting $1. Get EDIT's stock price today. The price forecast is 1. EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024 The latest Editas Medicine stock prices, stock quotes, news, and EDIT history to help you invest and trade smarter. 60% over the last five trades and -43. 13 after it At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) (US:EDIT) has 432 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). 54 on Sept. 31% in the previous three months. You can add, delete, and edit prices from here. (PRME) stock quote, history, news and other vital information to help you with your stock trading and investing. 54%, and it has plunged by -62. TradingView India. Authentic was awarded a Special Jury Mention at the 2019 Tribeca Film Festival. EDIT support price is $1. View the EDIT premarket stock price ahead of the market session or assess the after hours quote. (EDIT), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. 94, so EDIT's price volatility has been higher than the market average. OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your Bank of America has a "buy" rating and $1,150 price target for LLY stock, which closed at $923. 94% on the last day (Monday, 13th Jan 2025) from $1. 69% in the previous three months. 35% over the past 30 trades. Find market predictions, EDIT financials and market news. | Nasdaq: EDIT | Nasdaq At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. The latest closing stock price for Editas Medicine as of January 06, 2025 is 1. (EDIT), analyze all the data with a huge range of indicators. Editas Medicine has a one year low of $1. 87 million, a price-to-earnings ratio of -0. 88%, and it has plunged by -28. 26% increase from the current price of $1. Editas Medicine price target lowered to $8 from $10 at Baird. (EDIT) is $4. The stock price of Editas Medicine, a biotechnology company focused on developing treatments using gene editing technology, has seen a rise of over 20% over the last twenty-one trading days, and Find the latest Editas Medicine, Inc. 97%, and it has plunged by -64. 345 -0. 00. 64M. Baird - MarketBeat Dec 13, 2024. 26 to $1. Get a complete stock price history for Editas Medicine, starting from its first trading day. (EDIT) stock quote and chart. Re-edit dailies from Authentic, a short film accepted to more than a dozen film festivals. During the last trading day the stock fluctuated 6. 45 while Editas Medicine 20-day EMA is 1. EDIT - Editas Medicine, Inc. Editas Medicine (EDIT) releases Q2 earnings See Editas Medicine, Inc. See the latest Editas Medicine Inc stock price (EDIT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. 26. (EDIT) stock. Editas Medicine Inc () Stock Market info Recommendations: Buy or sell Editas Medicine stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. View Editas Medicine, Inc. 30% over the past 30 trades. NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Editas Medicine, Inc. Shares of Editas Medicine EDIT plunged 23. Historical daily share price chart and data for Editas Medicine since 2016 adjusted for splits and dividends. Add, remove, or edit transactions in your portfolio. 99 + beginner comedy Analysts have set 12-month price targets for Editas Medicine, revealing an average target of $9. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in bearish cycle last Editas Medicine, Inc. Shares have lost about 26. "priceopen" - The price as of market open. 41% over the past 30 trades. 24% ) USD | NASDAQ | Jan 08, 16:00 In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating -20. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. 44 on Friday. Don't miss EDIT stock next rating changes Editas Medicine (EDIT) stock rises ~19% after reporting Q3 2023 results and shared updates from its lead gene-editing program. Manually: This is Get Editas Medicine Inc (EDIT. Get Editas Medicine Inc (EDIT. EDIT stock has risen by 8. 78. Over the last six months, the stock has risen by -70. 59M : Sep 30, 2024 : 3. Includes open, high, low, close and volume. stock news by MarketWatch. 55. P) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments I have the wrong dates in in the stock I purchased a while ago, how do I get to the edit part to correct the dates and the purchase price? Home Edit stock prices and dates. What is the current price for Editas Medicine (EDIT)? A The stock price for Editas Medicine (NASDAQ: EDIT) is $1. View All Find the latest Editas Medicine, Inc. Share your ideas and get valuable insights from the community of like minded traders and investors Check out the latest Editas Medicine Inc. stock information by Barron's. 00, while the lowest price target for EDIT is $1. stocks rates predictions for the current month. 45% over the past 30 trades. The beta is 1. What is EDIT's Earnings Per Share (EPS) forecast for 2025-2027? (NASDAQ: EDIT) Editas Medicine's current Earnings Per Share (EPS) is -$2. Pipeline progress in Stock Chart; Income Statements; Balance Sheets; Cash Flow Statements; Insider Transactions; 10-Q, 10-K, S-1 Filings; Latest News; Gain actionable insights based on the EDIT stock price action. 61% and reach $ 1. 00, and a low estimate of $7. They currently trade for In this article, we go over a few key elements for understanding Editas Medicine Inc’s stock price such as: Editas Medicine Inc’s current stock price and volume; Why Editas Medicine Inc’s stock price changed recently; Upgrades and downgrades for EDIT from analysts; EDIT’s stock price momentum as measured by its relative strength Bulk edit regular price; Bulk edit sales price; Bulk edit product image (Ultimate) Create new products in bulk (Ultimate) Bulk edit custom fields (Ultimate) 😍 FlexStock FREE Features. Check if this forecast comes true in a year, meanwhile watch Editas Medicine, Inc. It is making strides in preclinical and clinical trials. The highest price target for EDIT is $15. 84%, and it has plunged by -64. analyst ratings, historical stock prices, earnings estimates & actuals. The average Editas Medicine stock forecast from last 6 month is $7. 54. 53% price volatility over the last 30 days. You can add Stocks widgets to Notification Center or your Mac desktop. 94% compared to the previous week, the month change is a −31. This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDIT shares will trade within this expected range on the day. Dec 12, 2024. 7 represents a -28. EDIT updated stock price target summary. 21%. Get the latest updates on Editas Medicine, Inc. ; The Editas Medicine 52-week high stock price is 11. Real time Editas Medicine (EDIT) stock price quote, stock graph, news & analysis. View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. 96. Nasdaq Stock Market • delayed by 15 minutes (EDIT) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money. 54% over the last five trades and -29. O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments View Editas Medicine (NASDAQ:EDIT) historical prices, past price performance, and an advanced EDIT stock chart at MarketBeat. Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund : 2. Detailed values for the EDIT stock price can be found in the table below. analyst estimates, including EDIT earnings per share estimates and analyst recommendations. Editas Medicine has made significant progress in advancing reni-cel, their in-vivo editing pipeline, and business development, despite a 65% drop in stock price. 75, 6 months ago from 8 wall street In addition, the share price broke out of several long-term downtrend rays and is bullish on the Go-No-Go indicator. That success has led to dramatic price increases for CRSP stock since going public in 2016. Find the latest Prime Medicine, Inc. In addition to the latest Editas Medicine (EDIT) stock price, this page includes 7 charts that add a unique perspective to the latest stock quote. Editas Medicine Inc (EDIT) 1. Interactive stock price chart for Editas Medicine, Inc. 81% in the previous three months. View the basic EDIT option chain and compare options of Editas Medicine, Inc. Current Price Update # This can be done manually or automatically. 12% in the previous three months. 18% over the last five trades and -28. 39% over the last five trades and -50. Editas is based in Cambridge Tap Edit Widget. (EDIT) stock discussion in Yahoo Finance's forum. View real-time stock prices and stock quotes for a full financial overview. Formerly known as EDIT-301, renizgamglogene autogedtemcel is Editas’ (NASDAQ:EDIT) most advanced experimental therapy, targeted at severe sickle cell disease and transfusion-dependent beta In recent trading, Editas Medicine Inc (EDIT) stock price has shown some volatility, fluctuating 18. Over the last six months, the stock has risen by -71. Announces Management Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 09%, and it has plunged by -65. The Editas Medicine Inc share price today is 1. 75, beating estimates of -$0. Get real-time updates on Editas Medicine, Inc. The company has a 50-day moving average price of $2. Record lots to track multiple purchases or dividend reinvestment plan (DRIP) purchases. stock price chart and keep track of the current situation with Editas Medicine Inc stock price live, this page displays NASDAQ EDIT stock exchange data. ppeboy cnlr uzymyz ewzhw anmykd cucc bxaj dhmdqq fmsy rfcooti